Botulinumtoxin Type-A (BoNTA) in the Management of Refractory Trigeminal Neuralgia: An Expert-Opinion, Practice-Oriented Narrative Review on Behalf of the GRASP Study Group

Trigeminal neuralgia (TN) ranks among the most excruciating neuropathic pain syndromes, characterized clinically by multiple daily episodes of unilateral, paroxysmal, electric shock-like facial pain. The daily activities and quality of life of affected patients are profoundly diminished. First-line...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Andreas A. Argyriou, Emmanouil V. Dermitzakis, Dimitrios Rikos, Georgia Xiromerisiou, Panagiotis Soldatos, Maria Chondrogianni, Eleni Mavraki, Michail Vikelis
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	MDPI AG 2026-05-01
סדרה:	Toxins
נושאים:	refractory trigeminal neuralgia pharmacotherapy botulinumtoxin type-A BoNTA
גישה מקוונת:	https://www.mdpi.com/2072-6651/18/6/248
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!